Mini-cog performance: novel marker of post discharge risk among patients hospitalized for heart failure

Apurva Patel1, Roosha Parikh1, Erik H Howell1

  • 1From the Department of Internal Medicine, Medicine Institute (A.P., R.P., E.H.H.), Section of Heart Failure and Cardiac Transplantation, Tomsich Family Department of Cardiovascular Medicine, Heart and Vascular Institute (E.H., E.Z.G.), and Center for Connected Care (E.Z.G.), Cleveland Clinic, Cleveland, OH; Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (S.H.L.); and Visiting Nurse Association Health Group, Red Bank, NJ (S.H.L.).

Insights

Cognitive impairment (CI) in heart failure (HF) patients, identified by the Mini-Cog, predicts higher readmission and mortality risk. Discharging HF patients with CI to a facility may offer protection compared to home discharge.

Area of Science:

  • Cardiology
  • Geriatrics
  • Neuropsychology

Background:

  • Current heart failure (HF) guidelines recommend screening for cognitive impairment (CI) but lack specific methods.
  • The Mini-Cog, an ultrashort cognitive assessment tool, has not been evaluated in HF patients post-hospitalization.

Purpose of the Study:

  • To assess if CI, measured by the Mini-Cog, correlates with increased risk of readmission or mortality after HF hospitalization.
  • To determine the predictive value of Mini-Cog performance for post-discharge outcomes in HF patients.

Main Methods:

  • Analysis of 720 HF patients who underwent Mini-Cog screening during hospitalization.
  • Primary outcome: time to first readmission or mortality post-discharge.
  • Utilized random survival forest analysis to identify key predictors among 55 variables.

Main Results:

  • A significant prevalence of CI (23%) was found using the Mini-Cog.
  • Poor Mini-Cog performance independently predicted a composite outcome of readmission or mortality (aHR=1.90).
  • Mini-Cog inclusion improved risk model accuracy and reclassification, demonstrating its clinical utility.

Conclusions:

  • Mini-Cog performance serves as a novel and significant marker for post-hospitalization risk in HF patients.
  • Discharging HF patients with CI to a facility, rather than home, may be a protective strategy.
  • Further research is needed to explore structured in-home support for HF patients with CI.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
963
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
649
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
789